Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2730-2733, July 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geldhof, A. B.
Right arrow Articles by De Baetselier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geldhof, A. B.
Right arrow Articles by De Baetselier, P.

Expression of B7-1 by Highly Metastatic Mouse T Lymphomas Induces Optimal Natural Killer Cell-mediated Cytotoxicity1

Anja B. Geldhof2, Geert Raes, Marleen Bakkus, Sophie Devos, Kris Thielemans and Patrick De Baetselier

Laboratory of Cellular Immunology, Flemish Institute for Biotechnology, Free University of Brussels, IMOL II, Paardenstraat 65, Sint Genesius Rode, 1640 [A. B. G., G. R., P. D.], and Laboratory of Physiology, Medical School, Free University of Brussels, Jette, 1090 [M. B., S. D., K. T.], Belgium

The interaction between B7-1 and CD28 provides costimulatory signals not only for T cells but also for natural killer (NK) cells. Highly metastatic mouse T lymphoma cells (BW-Li) can escape from NK cell-mediated killing by expressing H-2Dk molecules that negatively regulate NK lytic activity. We have analyzed whether B7-1:CD28 overrules the MHC class I-mediated inactivation of NK cells by transfecting BW-Li with the gene coding for B7-1. Expression of B7-1 rendered BW-Li cells sensitive toward NK cells. The experimental metastatic capacity of the B7-1 transfectants was drastically reduced in both syngeneic AKR and SCID mice but could be restored in SCID-bg mice. These results provide direct evidence that B7-1 expression leads to NK-mediated elimination of metastasizing, NK-resistant tumor cells.

1 This investigation was supported by grants from the GOA (P. D., K. T.) and the Governmental Vlaams Actieprogramma Biotechnologie (P. D.). P. D. is a research director of the Nationaal Fonds voor Wetenschappelijk Onderzoek (NFWO). S. D. holds a fellowship of the Vlaams Instituut voor de bevordering van het wetenschappelijk-technologisch onderzoek in de industrie. M. B. is a senior research assistant of the NFWO, and G. R. is a research assistant of the NFWO.

2 To whom requests for reprints should be addressed.

Received 3/29/95. Accepted 5/18/95.




This article has been cited by other articles:


Home page
BloodHome page
Z. Fan, P. Yu, Y. Wang, Y. Wang, M. L. Fu, W. Liu, Y. Sun, and Y.-X. Fu
NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors
Blood, February 15, 2006; 107(4): 1342 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Terme, E. Tomasello, K. Maruyama, F. Crepineau, N. Chaput, C. Flament, J.-P. Marolleau, E. Angevin, E. F. Wagner, B. Salomon, et al.
IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules
J. Immunol., May 15, 2004; 172(10): 5957 - 5966.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-X. Gao, X. Liu, J. Wen, M. A. Caligiuri, I. Stroynowski, P. Zheng, and Y. Liu
Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells
Blood, December 15, 2003; 102(13): 4456 - 4463.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. Geldhof, J. A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier
Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation
Blood, December 1, 2002; 100(12): 4049 - 4058.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Kelly, K. Takeda, P. K. Darcy, H. Yagita, and M. J. Smyth
A Role for IFN-{gamma} in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo
J. Immunol., May 1, 2002; 168(9): 4472 - 4479.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
J. Exp. Med., February 4, 2002; 195(3): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-F. Bai, J. Bender, J. Liu, H. Zhang, Y. Wang, O. Li, P. Du, P. Zheng, and Y. Liu
Local Costimulation Reinvigorates Tumor-Specific Cytolytic T Lymphocytes for Experimental Therapy in Mice with Large Tumor Burdens
J. Immunol., October 1, 2001; 167(7): 3936 - 3943.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Todo, R. L. Martuza, M. J. Dallman, and S. D. Rabkin
In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity
Cancer Res., January 1, 2001; 61(1): 153 - 161.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. L. Wilson, L. C. Heffler, J. Charo, A. Scheynius, M.-T. Bejarano, and H.-G. Ljunggren
Targeting of Human Dendritic Cells by Autologous NK Cells
J. Immunol., December 15, 1999; 163(12): 6365 - 6370.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Beissert, J. A. Bluestone, I. Mindt, M. Voskort, D. Metze, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe
Reduced Ultraviolet-Induced Carcinogenesis in Mice with a Functional Disruption in B7-Mediated Costimulation
J. Immunol., December 15, 1999; 163(12): 6725 - 6731.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Wilson, J. Charo, A. Martin-Fontecha, P. Dellabona, G. Casorati, B. J. Chambers, R. Kiessling, M.-T. Bejarano, and H.-G. Ljunggren
NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86
J. Immunol., October 15, 1999; 163(8): 4207 - 4212.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Galea-Lauri, D. Darling, S.-U. Gan, L. Krivochtchapov, M. Kuiper, J. Gaken, B. Souberbielle, and F. Farzaneh
Expression of a Variant of CD28 on a Subpopulation of Human NK Cells: Implications for B7-Mediated Stimulation of NK Cells
J. Immunol., July 1, 1999; 163(1): 62 - 70.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Tarte, X.-G. Zhang, E. Legouffe, C. Hertog, M. Mehtali, J.-F. Rossi, and B. Klein
Induced Expression of B7-1 on Myeloma Cells Following Retroviral Gene Transfer Results in Tumor-Specific Recognition by Cytotoxic T Cells
J. Immunol., July 1, 1999; 163(1): 514 - 524.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Moro, A. M. Gasparri, S. Pagano, M. Bellone, P. Tornaghi, F. Veglia, A. Corti, G. Casorati, and P. Dellabona
Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules
Cancer Res., June 1, 1999; 59(11): 2650 - 2656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Schneeberger, F. Koszik, W. Schmidt, R. Kutil, and G. Stingl
The Tumorigenicity of IL-2 Gene-Transfected Murine M-3D Melanoma Cells Is Determined by the Magnitude and Quality of the Host Defense Reaction: NK Cells Play a Major Role
J. Immunol., June 1, 1999; 162(11): 6650 - 6657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. N. L. Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr
Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism
J. Immunol., April 15, 1999; 162(8): 4817 - 4823.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Seko, N. Takahashi, M. Azuma, H. Yagita, K. Okumura, and Y. Yazaki
Expression of Costimulatory Molecule CD40 in Murine Heart With Acute Myocarditis and Reduction of Inflammation by Treatment With Anti-CD40L/B7-1 Monoclonal Antibodies
Circ. Res., August 24, 1998; 83(4): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Seko, N. Takahashi, M. Azuma, H. Yagita, K. Okumura, and Y. Yazaki
Effects of In Vivo Administration of Anti–B7-1/B7-2 Monoclonal Antibodies on Murine Acute Myocarditis Caused by Coxsackievirus B3
Circ. Res., March 23, 1998; 82(5): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. Geldhof, M. Moser, L. Lespagnard, K. Thielemans, and P. De Baetselier
Interleukin-12-Activated Natural Killer Cells Recognize B7 Costimulatory Molecules on Tumor Cells and Autologous Dendritic Cells
Blood, January 1, 1998; 91(1): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. M. Putzer, M. Hitt, W. J. Muller, P. Emtage, J. Gauldie, and F. L. Graham
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
PNAS, September 30, 1997; 94(20): 10889 - 10894.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.